
Christopher Brian Mckinley
Examiner (ID: 13265)
| Most Active Art Unit | 3781 |
| Art Unit(s) | 3781 |
| Total Applications | 591 |
| Issued Applications | 270 |
| Pending Applications | 9 |
| Abandoned Applications | 315 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19883291
[patent_doc_number] => 12268977
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-08
[patent_title] => Compounds for separation of rare earth elements and s-, p-, d-metals, method of separation, and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/768169
[patent_app_country] => US
[patent_app_date] => 2018-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 30934
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 230
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16768169
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/768169 | Compounds for separation of rare earth elements and s-, p-, d-metals, method of separation, and use thereof | Nov 29, 2018 | Issued |
Array
(
[id] => 20385481
[patent_doc_number] => 12485191
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-02
[patent_title] => Radiopharmaceuticals and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/765507
[patent_app_country] => US
[patent_app_date] => 2018-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 29
[patent_no_of_words] => 12366
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16765507
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/765507 | Radiopharmaceuticals and methods of use thereof | Nov 27, 2018 | Issued |
Array
(
[id] => 16468138
[patent_doc_number] => 20200369675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => Imaging Agents
[patent_app_type] => utility
[patent_app_number] => 16/767896
[patent_app_country] => US
[patent_app_date] => 2018-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12974
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16767896
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/767896 | Imaging Agents | Nov 26, 2018 | Abandoned |
Array
(
[id] => 15946195
[patent_doc_number] => 10660976
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-26
[patent_title] => Compositions and methods for AL amyloid detection and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/181628
[patent_app_country] => US
[patent_app_date] => 2018-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 13773
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16181628
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/181628 | Compositions and methods for AL amyloid detection and uses thereof | Nov 5, 2018 | Issued |
Array
(
[id] => 14775163
[patent_doc_number] => 20190262479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => IMAGING METHOD FOR DIFFUSE INTRINSIC PONTINE GLIOMA USING AN IMAGING AGENT, AND IMAGING AGENTS FOR EARLY STAGE DIAGNOSES
[patent_app_type] => utility
[patent_app_number] => 16/176658
[patent_app_country] => US
[patent_app_date] => 2018-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5819
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16176658
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/176658 | IMAGING METHOD FOR DIFFUSE INTRINSIC PONTINE GLIOMA USING AN IMAGING AGENT, AND IMAGING AGENTS FOR EARLY STAGE DIAGNOSES | Oct 30, 2018 | Abandoned |
Array
(
[id] => 14773921
[patent_doc_number] => 20190261858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => IMAGING METHOD FOR ACUTE LYMPHOBLASTIC LEUKEMIA USING AN IMAGING AGENT AND METHOD OF PRODUCING AN IMAGING AGENT
[patent_app_type] => utility
[patent_app_number] => 16/176352
[patent_app_country] => US
[patent_app_date] => 2018-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13977
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16176352
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/176352 | IMAGING METHOD FOR ACUTE LYMPHOBLASTIC LEUKEMIA USING AN IMAGING AGENT AND METHOD OF PRODUCING AN IMAGING AGENT | Oct 30, 2018 | Abandoned |
Array
(
[id] => 19354034
[patent_doc_number] => 12054463
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-06
[patent_title] => Radiolabeled microtubule imaging compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/646630
[patent_app_country] => US
[patent_app_date] => 2018-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 16
[patent_no_of_words] => 17246
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16646630
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/646630 | Radiolabeled microtubule imaging compounds and uses thereof | Oct 29, 2018 | Issued |
Array
(
[id] => 18792701
[patent_doc_number] => 11826435
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-28
[patent_title] => Conduritol aziridine derivatives and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/756872
[patent_app_country] => US
[patent_app_date] => 2018-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 29197
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16756872
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/756872 | Conduritol aziridine derivatives and uses thereof | Oct 18, 2018 | Issued |
Array
(
[id] => 14531883
[patent_doc_number] => 20190201562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => Compositions And Methods For In Vivo Imaging
[patent_app_type] => utility
[patent_app_number] => 16/147370
[patent_app_country] => US
[patent_app_date] => 2018-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16147370
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/147370 | Compositions and methods for in vivo imaging | Sep 27, 2018 | Issued |
Array
(
[id] => 18201223
[patent_doc_number] => 11583596
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-21
[patent_title] => Radiolabeled Darapladib and analogs thereof and their use as imaging compounds
[patent_app_type] => utility
[patent_app_number] => 16/650532
[patent_app_country] => US
[patent_app_date] => 2018-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 25
[patent_no_of_words] => 11420
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16650532
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/650532 | Radiolabeled Darapladib and analogs thereof and their use as imaging compounds | Sep 25, 2018 | Issued |
Array
(
[id] => 16282736
[patent_doc_number] => 20200276338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => BIOREDUCTIVELY-ACTIVATED COMPOUNDS, THEIR PRODRUGS, RADIOPHARMACEUTICALS, THE COMPOSITIONS, AND THEIR APPLICATIONS IN MULTIMODAL THERANOSTIC MANAGEMENT OF HYPOXIA DISEASES INCLUDING CANCER
[patent_app_type] => utility
[patent_app_number] => 16/648408
[patent_app_country] => US
[patent_app_date] => 2018-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12170
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16648408
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/648408 | BIOREDUCTIVELY-ACTIVATED COMPOUNDS, THEIR PRODRUGS, RADIOPHARMACEUTICALS, THE COMPOSITIONS, AND THEIR APPLICATIONS IN MULTIMODAL THERANOSTIC MANAGEMENT OF HYPOXIA DISEASES INCLUDING CANCER | Sep 18, 2018 | Abandoned |
Array
(
[id] => 13585345
[patent_doc_number] => 20180344221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => SWEAT MONITORING AND CONTROL OF DRUG DELIVERY
[patent_app_type] => utility
[patent_app_number] => 16/100629
[patent_app_country] => US
[patent_app_date] => 2018-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10959
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16100629
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/100629 | SWEAT MONITORING AND CONTROL OF DRUG DELIVERY | Aug 9, 2018 | Abandoned |
Array
(
[id] => 17799093
[patent_doc_number] => 11413360
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-16
[patent_title] => Dual mode radiotracer and--therapeutics
[patent_app_type] => utility
[patent_app_number] => 16/634759
[patent_app_country] => US
[patent_app_date] => 2018-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 16704
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16634759
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/634759 | Dual mode radiotracer and--therapeutics | Jul 29, 2018 | Issued |
Array
(
[id] => 15071019
[patent_doc_number] => 10464985
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-05
[patent_title] => Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
[patent_app_type] => utility
[patent_app_number] => 16/039858
[patent_app_country] => US
[patent_app_date] => 2018-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 17541
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16039858
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/039858 | Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same | Jul 18, 2018 | Issued |
Array
(
[id] => 16853439
[patent_doc_number] => 20210154184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => COMPOUNDS FOR TAU PROTEIN DEGRADATION
[patent_app_type] => utility
[patent_app_number] => 16/630294
[patent_app_country] => US
[patent_app_date] => 2018-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47163
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -72
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16630294
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/630294 | COMPOUNDS FOR TAU PROTEIN DEGRADATION | Jul 11, 2018 | Abandoned |
Array
(
[id] => 14406481
[patent_doc_number] => 20190169084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => CONJUGATES DERIVED FROM NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND METHODS OF USE THEREOF IN IMAGING
[patent_app_type] => utility
[patent_app_number] => 16/025826
[patent_app_country] => US
[patent_app_date] => 2018-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36858
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16025826
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/025826 | CONJUGATES DERIVED FROM NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND METHODS OF USE THEREOF IN IMAGING | Jul 1, 2018 | Abandoned |
Array
(
[id] => 16221378
[patent_doc_number] => 20200246494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => LU-CONTAINING COMPOSITIONS AND METHODS OF PRODUCING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/637299
[patent_app_country] => US
[patent_app_date] => 2018-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7032
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16637299
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/637299 | LU-CONTAINING COMPOSITIONS AND METHODS OF PRODUCING THE SAME | Jun 28, 2018 | Abandoned |
Array
(
[id] => 15799923
[patent_doc_number] => 20200123104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => PHARMACEUTICAL AGENT THAT BINDS THE P2X7 RECEPTOR
[patent_app_type] => utility
[patent_app_number] => 16/626723
[patent_app_country] => US
[patent_app_date] => 2018-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6155
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16626723
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/626723 | PHARMACEUTICAL AGENT THAT BINDS THE P2X7 RECEPTOR | Jun 27, 2018 | Abandoned |
Array
(
[id] => 13504807
[patent_doc_number] => 20180303946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => CROSSLINKED POLYSACCHARIDE BEADS COMPRISING AN IMAGING AGENT
[patent_app_type] => utility
[patent_app_number] => 16/019815
[patent_app_country] => US
[patent_app_date] => 2018-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12105
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 193
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16019815
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/019815 | CROSSLINKED POLYSACCHARIDE BEADS COMPRISING AN IMAGING AGENT | Jun 26, 2018 | Abandoned |
Array
(
[id] => 17334707
[patent_doc_number] => 20220001038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => CONJUGATES FOR DETECTION OF AXILLARY LYMPH NODE METASTASES
[patent_app_type] => utility
[patent_app_number] => 16/625354
[patent_app_country] => US
[patent_app_date] => 2018-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7981
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16625354
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/625354 | CONJUGATES FOR DETECTION OF AXILLARY LYMPH NODE METASTASES | Jun 20, 2018 | Abandoned |